Jazz Pharmaceuticals Corp (JAZZ) Cash Calculated per Single Share

Symbol and logo of brand jazzpharma.com (JAZZ)

Jazz Pharmaceuticals has created a unique neurobiological ecosystem where patents for sleep aids keep patients within a closed loop. The cash per share figure clearly demonstrates this success. A monopoly in the treatment of narcolepsy guarantees a steady stream of high-margin profits, while the implementation of Scope 3 auditing confirms environmental responsibility. The value of 44.41 shapes the current metric indicator.

jazzpharma.com (JAZZ): Cash per Single Share from 07/04/2022 to 11/20/2026

Analytical breakdowns for Jazz Pharmaceuticals plc (JAZZ)

- market price and analyst price targets:
- cash and cash flow data:
Comprehensive company analysis:Jazz Pharma (JAZZ)
Manufactured products of jazzpharma.com

Investors use this indicator to assess financial stability and the business's ability to withstand external shocks. The metric is calculated as the ratio of total cash to the number of shares outstanding, allowing Jazz Pharmaceuticals (JAZZ) to mitigate the risks of supply chain disruptions in Asia by monitoring the current cash per share as a liquidity buffer.